컴파운딩 약국 시장(2026-2030년)

The global compounding pharmacy market is forecasted to grow by USD 1725.6 mn during 2025-2030, accelerating at a CAGR of 2.1% during the forecast period. The report on the global compounding pharmacy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of hrt fueling demand for compounded medications, increasing prevalence of hormonal imbalance problems, government regulations and initiatives expediting market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global compounding pharmacy market is segmented as below:

By Product

• Topical medications
• Oral medications
• Parenteral medications
• Others

By Therapeutic Area

• Pain management
• Hormone replacement
• Dermal disorders
• Others

By End-User

• Hospital pharmacies
• Retail pharmacies
• Long-term care facilities
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rising popularity of personalized medicines as one of the prime reasons driving the global compounding pharmacy market growth during the next few years. Also, untapped opportunities in emerging markets and improvisation of essential drugs fostering market growth will lead to sizable demand in the market.

The report on the global compounding pharmacy market covers the following areas:

• Global compounding pharmacy market sizing
• Global compounding pharmacy market forecast
• Global compounding pharmacy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global compounding pharmacy market vendors that include AnazaoHealth, Bayview Pharmacy, Belmar Pharma, CAPS Pharmacy, Clinigen Group Plc, Empower Pharmacy, Fagron NV, Fresenius Kabi AG, McGuff, Nephron Pharmaceuticals, Olympia Pharmacy, Pavilion Pharmacy, QuVa Pharma, SCA Pharma, T and C Compounding, Wedgewood Pharmacy, Wells Pharmacy. Also, the global compounding pharmacy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Therapeutic Area
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Compounding Pharmacy Market 2020 - 2024
  • Historic Market Size - Data Table on Global Compounding Pharmacy Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Therapeutic Area segment analysis 2020 - 2024
  • Historic Market Size - Therapeutic Area Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Compounding Pharmacy Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Topical medications - Market size and forecast 2025-2030
• 8.4 Oral medications - Market size and forecast 2025-2030
• 8.5 Parenteral medications - Market size and forecast 2025-2030
• 8.6 Others - Market size and forecast 2025-2030
• 8.7 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Therapeutic Area

• 9.1 Market segments
• 9.2 Comparison by Therapeutic Area
• 9.3 Pain management - Market size and forecast 2025-2030
• 9.4 Hormone replacement - Market size and forecast 2025-2030
• 9.5 Dermal disorders - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by Therapeutic Area
  • Market opportunity by Therapeutic Area ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospital pharmacies - Market size and forecast 2025-2030
• 10.4 Retail pharmacies - Market size and forecast 2025-2030
• 10.5 Long-term care facilities - Market size and forecast 2025-2030
• 10.6 Others - Market size and forecast 2025-2030
• 10.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Growing popularity of HRT fueling demand for compounded medications
  • Increasing prevalence of hormonal imbalance problems
  • Government regulations and initiatives expediting market growth
• 13.2 Market challenges
  • Unsafe usage of compounded drugs
  • Stringent scrutiny of compounded medications
  • Recalls of pharmaceutical products
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Rising popularity of personalized medicines
  • Untapped opportunities in emerging markets
  • Improvisation of essential drugs fostering market growth

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AnazaoHealth
  • AnazaoHealth - Overview
  • AnazaoHealth - Product / Service
  • AnazaoHealth - Key offerings
  • SWOT
• 15.5 Bayview Pharmacy
  • Bayview Pharmacy - Overview
  • Bayview Pharmacy - Product / Service
  • Bayview Pharmacy - Key offerings
  • SWOT
• 15.6 Belmar Pharma
  • Belmar Pharma - Overview
  • Belmar Pharma - Product / Service
  • Belmar Pharma - Key offerings
  • SWOT
• 15.7 CAPS Pharmacy
  • CAPS Pharmacy - Overview
  • CAPS Pharmacy - Product / Service
  • CAPS Pharmacy - Key offerings
  • SWOT
• 15.8 Clinigen Group Plc
  • Clinigen Group Plc - Overview
  • Clinigen Group Plc - Product / Service
  • Clinigen Group Plc - Key offerings
  • SWOT
• 15.9 Empower Pharmacy
  • Empower Pharmacy - Overview
  • Empower Pharmacy - Product / Service
  • Empower Pharmacy - Key offerings
  • SWOT
• 15.10 Fagron NV
  • Fagron NV - Overview
  • Fagron NV - Business segments
  • Fagron NV - Key offerings
  • Fagron NV - Segment focus
  • SWOT
• 15.11 Fresenius Kabi AG
  • Fresenius Kabi AG - Overview
  • Fresenius Kabi AG - Product / Service
  • Fresenius Kabi AG - Key offerings
  • SWOT
• 15.12 McGuff
  • McGuff - Overview
  • McGuff - Product / Service
  • McGuff - Key offerings
  • SWOT
• 15.13 Olympia Pharmacy
  • Olympia Pharmacy - Overview
  • Olympia Pharmacy - Product / Service
  • Olympia Pharmacy - Key offerings
  • SWOT
• 15.14 Pavilion Pharmacy
  • Pavilion Pharmacy - Overview
  • Pavilion Pharmacy - Product / Service
  • Pavilion Pharmacy - Key offerings
  • SWOT
• 15.15 QuVa Pharma
  • QuVa Pharma - Overview
  • QuVa Pharma - Product / Service
  • QuVa Pharma - Key offerings
  • SWOT
• 15.16 SCA Pharma
  • SCA Pharma - Overview
  • SCA Pharma - Product / Service
  • SCA Pharma - Key offerings
  • SWOT
• 15.17 Wedgewood Pharmacy
  • Wedgewood Pharmacy - Overview
  • Wedgewood Pharmacy - Product / Service
  • Wedgewood Pharmacy - Key offerings
  • SWOT
• 15.18 Wells Pharmacy
  • Wells Pharmacy - Overview
  • Wells Pharmacy - Product / Service
  • Wells Pharmacy - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations